Jane Street’s HUMANIGEN, INC. HGEN Stock Holding History

Jane Street’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-152,300	Closed	-$458K	–	11315
2022 Q1	$458K	Buy	152,300 +41,400	+37%	+$111K	﹤0.01%	7654
2021 Q4	$413K	Sell	110,900 -130,000	-54%	-$761K	﹤0.01%	7596
2021 Q3	$1.43M	Buy	240,900 +12,900	+6%	+$181K	﹤0.01%	5185
2021 Q2	$3.96M	Buy	228,000 +94,100	+70%	+$1.72M	﹤0.01%	3050
2021 Q1	$2.56M	Buy	+133,900	New	+$2.44M	﹤0.01%	3556

Other funds holding HGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's HGEN Position: Q1 2023 in Review

Jane Street sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 19,768 shares — an estimated $2.37K sold.

Jane Street first reported a position in HGEN in Q1 2021 and held it in 7 quarters. The position peaked at $4.11M in Q2 2021. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

Jane Street reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 19,768 HUMANIGEN, INC. shares in Q1 2023, an estimated $2.37K.
Jane Street first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 7 quarters.
Jane Street's HUMANIGEN, INC. position peaked at $4.11M in Q2 2021.
42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.